Chinese scientists and their U.S. counterparts have developed two cocktail antibodies against COVID-19 that may deliver a one-two punch to infections caused by the prevalent Omicron variant.
Researchers from the University of Science and Technology of China, the Chinese Academy of Sciences and the University of Texas Health Science Center at San Antonio designed bivalent nanobodies that can provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron.
These variants with adaptive mutations have caused fresh outbreaks even amongst vaccinated populations.
In the two new experimental medicines, the researchers fused an antibody called aRBD-2 with another two aRBD-5 and aRBD-7, respectively, according to the study published recently in the journal Cell Research.
The detection of their crystal structures reveals that those three nanobodies can neutralize the coronavirus by binding with a highly-conserved place in the virus's spike protein, according to the study.
Furthermore, aRBD-5 and aRBD-7 are capable of binding to a less-conserved place in the virus protein, thus effectively enhancing the overall binding affinity of the two-in-one antibodies.
The cellular assays demonstrated that the two combined nanobodies, aRBD-2-5 and aRBD-2-7, retain strong neutralization activity against all the tested major variants, including Omicron BA.1, BA.1.1 and BA.2.
In a Syrian golden hamster model, aRBD-2-5 works to eliminate Omicron BA.1 virus, according to the study.
The strategy provides new solutions in the development of broad-spectrum therapeutic antibodies for COVID-19, the researchers said.
- Chinese scientists find new way for robust DNA data storage: Nature
- Chinese scientists discover new lunar mineral
- Xi extends sympathy to Japanese PM over COVID-19 infection
- Three scientists win China’s 2022 Future Science Prize
- China’s first COVID-19 oral medicine covered by medical insurance
- Scientists design two-in-one antibodies against COVID-19 variants
Popular Videos
Hot comments
- First apes at U.S. zoo receive COVID-19 vaccine made for animals, zoo official says
- China Life: Chinese women shine with She Power
- Foreign firms approved to offer VPN services in capital
- Homemade curling videos trending in China
- 86-year-old grandma in Hebei spends most her life on traditional cheongsam
- Winners of 2022 Inaugural WLA Prize announced
- Lantern Festival: A romantic celebration in China
- Two Chinese COVID-19 vaccine firms to supply vaccines to COVAX
- Media center for 20th CPC national congress to open on Oct. 12
- Six suspects arrested in HK for role in SE Asia job scam
Top Reviews
- Young artists recreate beauty of traditional Hanfu costume
- China releases photos of tallest tree
- English version of ‘Understanding Xi Jinping’s Educational Philosophy’ published
- China crowned in men’s team for 10th straight time at table tennis worlds
- China publishes Atlas of Wildlife in SW China
- Guangxi’s 10 Years: A Visit to China’s Qinzhou Port
- Congress delegate helped lift village out of poverty
- Expo highlights joint efforts in NEV development
- Racism stain of shame on ‘world democratic paradise’
- U.S. may face new COVID wave this upcoming winter: report